LONDON, UNITED KINGDOM--(Marketwire - February 06, 2008) - NextGen Bioscience, Inc. (“NextGen”) (NASDAQ: NXGB), a biotechnology company that develops novel therapeutic proteins that disrupt the advance of life-threatening cancers, today announced the formation of a Scientific Advisory Board (SAB) comprised of three well-known industry leaders.
